DARPins as a novel tool to detect and degrade p73
2024

Using DARPins to Target and Degrade p73 Protein

publication 10 minutes Evidence: moderate

Author Information

Author(s): Münick Philipp, Zielinski Jasmin, Strubel Alexander, Gutfreund Niklas, Dreier Birgit, Schaefer Jonas V., Schäfer Birgit, Gebel Jakob, Osterburg Christian, Chaikuad Apirat, Knapp Stefan, Plückthun Andreas, Dötsch Volker

Primary Institution: Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany

Hypothesis

Can DARPins be used to selectively degrade the p73 protein?

Conclusion

The study demonstrates that DARPins can effectively target and degrade specific isoforms of the p73 protein, potentially offering a new therapeutic approach.

Supporting Evidence

  • DARPins were shown to selectively bind to p73 isoforms without affecting p63.
  • Binding affinities of DARPins to p73 domains were measured using isothermal titration calorimetry.
  • BioPROTACs created from DARPins effectively degraded p73 in cell cultures.

Takeaway

Researchers created special proteins called DARPins that can find and break down a specific protein in cells, which could help treat diseases.

Methodology

The study involved creating DARPins that bind to specific domains of p73, followed by testing their ability to degrade the protein in cell cultures and tissue samples.

Limitations

The study primarily focused on in vitro experiments, and the effectiveness in vivo remains to be established.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41419-024-07304-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication